PTSD: Identifying Risk and Current and Future Interventions

Wednesday, September 1, 2021
PTSD: Identifying Risk and Current and Future Interventions

Although most of us will be exposed to at least one traumatic event in our lifetime, only a small fraction of us will go on to develop post-traumatic stress disorder (PTSD). Dr. Risbrough will discuss the current understanding of potential mechanisms underlying risk factors for development of PTSD after trauma and the current strategies for developing and testing novel treatments.

Watch webinar recording:

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presented by 
Victoria B. Risbrough, Ph.D.
Victoria B. Risbrough, Ph.D.
University of California San Diego

Associate Director of Neuroscience, Center of Excellence for Stress and Mental Health, VA San Diego Healthcare System

Professor of Psychiatry

Scientific Council Member (Joined 2017)


Dr. Risbrough is a Professor of Psychiatry at the University of California San Diego and Associate Director of Neuroscience for the Center of Excellence for Stress and Mental Health for Veterans Affairs. Her research is centered on translational mechanisms and treatments of anxiety and depression particularly trauma-related disorders. She leads a dual preclinical/clinical research program focusing on identifying mechanisms of risk and resilience to post-traumatic stress disorder, as well as development of new pharmacological treatments for these disorders. She uses homologous physiological and behavioral measures of trauma response across rodents and humans to develop translational probes of anxiety responding and treatment efficacy. Her preclinical laboratory uses behavioral, pharmacological, genetic and molecular techniques to identify genetic and circuit mechanisms of enduring trauma responses. Her clinical work examines mechanisms underlying core disruptions of fear learning and inhibition in trauma-related disorders, as well as development of novel pharmacological treatments targeting these mechanisms. Examples of her clinical work include her directorship of the Neurocognition Project of the Marine Resiliency Study, assessing neurocognitive, biological and psychophysiological markers of risk for PTSD in combat exposed individuals. She is on the Scientific Council for the Anxiety and Depression Association of America, is a Member of the American College of Neuropharmacology and is Associate Editor of Neurobiology of Stress. She has received funding from NARSAD, NIDA, NIMH, VA, DOD and TRDRP and Navy BUMED.

Moderated by 
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO


Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.